Synovial Sarcoma clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 12 years and up
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in solid tumors
Our lead scientists for Synovial Sarcoma research studies include Brian Schulte, MD.